Total Payments
$20,967
2024 Payments
$3,169
Companies
39
Transactions
1,338
Medicare Patients
8,823
Medicare Billing
$7.4M
Payment Breakdown by Category
Food & Beverage$20,910 (99.7%)
Education$57.56 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,910 | 1,333 | 99.7% |
| Education | $57.56 | 5 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,558 | 210 | $0 (2024) |
| Amgen Inc. | $2,757 | 175 | $0 (2024) |
| PFIZER INC. | $2,170 | 146 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,794 | 119 | $0 (2024) |
| Janssen Biotech, Inc. | $1,536 | 87 | $0 (2024) |
| UCB, Inc. | $1,450 | 142 | $0 (2024) |
| Lilly USA, LLC | $1,380 | 67 | $0 (2024) |
| Horizon Therapeutics plc | $894.64 | 56 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $886.08 | 64 | $0 (2024) |
| GlaxoSmithKline, LLC. | $792.40 | 47 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,169 | 161 | ABBVIE INC. ($706.93) |
| 2023 | $3,018 | 165 | AbbVie Inc. ($866.06) |
| 2022 | $2,701 | 162 | ABBVIE INC. ($704.29) |
| 2021 | $2,513 | 163 | AbbVie Inc. ($547.81) |
| 2020 | $2,101 | 138 | Amgen Inc. ($499.89) |
| 2019 | $2,649 | 192 | Amgen Inc. ($460.76) |
| 2018 | $2,556 | 172 | PFIZER INC. ($524.44) |
| 2017 | $2,259 | 185 | PFIZER INC. ($478.06) |
All Payment Transactions
1,338 individual payment records from CMS Open Payments — Page 1 of 54
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Immunology | ||||||
| 12/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.26 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $11.37 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/13/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/13/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $2.35 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/11/2024 | Fresenius Kabi USA, LLC | — | Food and Beverage | In-kind items and services | $22.34 | General |
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $25.30 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), TREMFYA, REMICADE | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Immunology | ||||||
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $26.68 | General |
| Category: Inflammation | ||||||
| 11/27/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: Dermatology | ||||||
| 11/26/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/25/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Inflammation | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: Bone Health | ||||||
| 11/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $1.32 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $29.57 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/12/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $26.66 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/06/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $28.62 | General |
| Category: Immunology | ||||||
| 11/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $6.84 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 2,127 | 169,231 | $4.6M | $1.8M |
| 2022 | 20 | 1,677 | 146,882 | $4.5M | $1.8M |
| 2021 | 27 | 1,861 | 139,450 | $4.0M | $2.0M |
| 2020 | 42 | 3,158 | 152,674 | $3.4M | $1.8M |
Total Patients
8,823
Total Services
608,237
Medicare Billing
$7.4M
Procedure Codes
116
All Medicare Procedures & Services
116 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 39 | 18,125 | $1.1M | $610,143 | 56.3% |
| J3262 | Injection, tocilizumab, 1 mg | Office | 2023 | 20 | 74,640 | $597,120 | $349,617 | 58.6% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2023 | 43 | 25,750 | $1.2M | $270,128 | 23.3% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2023 | 25 | 6,561 | $656,100 | $143,647 | 21.9% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 13 | 34,000 | $510,000 | $132,655 | 26.0% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 37 | 4,020 | $102,600 | $73,090 | 71.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 331 | 787 | $133,790 | $67,180 | 50.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 240 | 481 | $57,720 | $28,166 | 48.8% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 56 | 299 | $74,750 | $26,786 | 35.8% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 92 | 432 | $54,000 | $19,847 | 36.8% |
| J7325 | Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | Office | 2023 | 11 | 1,104 | $27,600 | $8,117 | 29.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 60 | 60 | $15,600 | $6,803 | 43.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 276 | 621 | $6,054 | $5,004 | 82.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 63 | 106 | $15,330 | $4,940 | 32.2% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 30 | 168 | $16,800 | $3,073 | 18.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 60 | 263 | $10,520 | $2,724 | 25.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 154 | 242 | $6,050 | $2,425 | 40.1% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 57 | 57 | $12,825 | $2,001 | 15.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 151 | 242 | $6,050 | $1,786 | 29.5% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 11 | 19 | $3,040 | $1,408 | 46.3% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2023 | 111 | 137 | $2,055 | $686.53 | 33.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 86 | 858 | $4,290 | $641.00 | 14.9% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 16 | 80 | $16,000 | $513.58 | 3.2% |
| 73120 | X-ray of hand, 2 views | Office | 2023 | 13 | 19 | $855.00 | $439.09 | 51.4% |
| 85652 | Red blood cell sedimentation rate, to detect inflammation, automated | Office | 2023 | 108 | 134 | $2,010 | $347.52 | 17.3% |
About Elizabeth Simpson
Elizabeth Simpson is a Internal Medicine healthcare provider based in Hixson, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1295848794.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Elizabeth Simpson has received a total of $20,967 in payments from pharmaceutical and medical device companies, with $3,169 received in 2024. These payments were reported across 1,338 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($20,910).
As a Medicare-enrolled provider, Simpson has provided services to 8,823 Medicare beneficiaries, totaling 608,237 services with total Medicare billing of $7.4M. Data is available for 4 years (2020–2023), covering 116 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Rheumatology
- Location Hixson, TN
- Active Since 08/17/2006
- Last Updated 03/24/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1295848794
Products in Payments
- RINVOQ (Biological) $2,116
- XELJANZ (Drug) $1,578
- Cimzia (Drug) $1,383
- Enbrel (Biological) $1,342
- COSENTYX (Biological) $1,300
- TALTZ (Drug) $1,278
- KRYSTEXXA (Biological) $992.05
- ORENCIA (Biological) $886.08
- BENLYSTA (Biological) $792.40
- TREMFYA (Drug) $780.26
- EVENITY (Biological) $564.47
- SKYRIZI (Biological) $515.57
- COSENTYX (Drug) $477.67
- Humira (Biological) $461.61
- SIMPONI ARIA (Biological) $416.14
- LYRICA (Drug) $384.52
- Tymlos (Biological) $337.24
- Actemra (Biological) $320.61
- Rituxan (Biological) $318.90
- ACTHAR (Biological) $259.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Hixson
Dr. Oana Andreescu, Md, MD
Internal Medicine — Payments: $11,916
Internal Medicine $11,916
Samuel Abbas, Md, MD
Internal Medicine — Payments: $9,081
Internal Medicine $9,081
Dr. David Phillips, Md, MD
Internal Medicine — Payments: $5,398
Internal Medicine $5,398
James Stanko, Md, MD
Internal Medicine — Payments: $5,161
Internal Medicine $5,161
Melanie Blake, Md, MD
Internal Medicine — Payments: $3,284
Internal Medicine $3,284
Dr. Amanda Winters, D.o, D.O
Internal Medicine — Payments: $939.06
Internal Medicine $939.06